Leigh Ann White

PhD, Senior Director, Evidence Synthesis, Modeling & Communication

Leigh Ann leads client engagements with a focus on developing product value stories, global value dossiers, and AMCP dossiers. Previously, Leigh Ann served as an associate director in global market access for Biogen’s neuroscience assets including Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). Prior to her tenure at Biogen, Leigh Ann worked for Analysis Group and Boston Health Economics, conducting health economics and outcomes research for biotechnology company clients. She has published systematic reviews, economic models, epidemiology and health outcomes studies in disease areas such as ALS, multiple sclerosis, pain conditions, psychiatric illnesses, rheumatoid arthritis, and oncology. She is adept at organizing efforts to seek payer advice through advisory boards and more formal early scientific advice procedures, as well as communicating product value from cost-effectiveness and budget impact model results. Leigh Ann draws on her deep experience to provide clients with communications services that fit a product’s stage of clinical development and overall market access strategy.

Leigh Ann earned a PhD in health economics from the Johns Hopkins Bloomberg School of Public Health. She also holds a Masters in demography (population studies) from Georgetown University and a BA in mathematics from Sweet Briar College.